Skip to content

No-tox Vs. Retinoid (Tretinoin) Study: Comparison of the wrinkle reduction performance of a cosmeceutical non-toxin based wrinkle-reducing serum against a pharmaceutical prescription-grade retinol

A randomised, controlled comparative study the wrinkle reduction benefits of No-Tox, a plukenetia/niacinamide/plankton-based topical cosmeceutical formulation vs. 0.5 mg (0.05% w/w) tretinoin, a pharmaceutical prescription-strength topical retinoic acid formulation in healthy adults

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621001735842
Acronym
NOVRET (No-tox Vs. Retinoid Study)
Enrollment
60
Registered
2021-12-20
Start date
2027-05-03
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sun damage caused photo-aging that results in wrinkles causing concern to the individuals who often seek medical or cosmetic treatments. This study aims to compare the efficacy of No-Tox, a commercially available proprietary plant-and-plankton based cosmeceutical formulation vs. a prescription-grade pharmaceutical formulation ( 0·05 mg/g Tretinoin) in improving the appearance of facial wrinkles.

Interventions

No-Tox serum (manufactured under license by Smoothe Inc, DE, USA) will be applied twice daily over wrinkled areas of the face (4-5 drops twice daily as recommended by the manufacturers). The cosmetic formulation contains plukenitia volubis, niacinamide, hyaluronic acid and plankton extracts (detailed ingredient list under documents) Measurements and clinical reviews will be undertaken at 1-month and 3-month periods on healthy adult volunteers. The amount of product provided has been estimated to

No-Tox serum (manufactured under license by Smoothe Inc, DE, USA) will be applied twice daily over wrinkled areas of the face (4-5 drops twice daily as recommended by the manufacturers). The cosmetic formulation contains plukenitia volubis, niacinamide, hyaluronic acid and plankton extracts (detailed ingredient list under documents) Measurements and clinical reviews will be undertaken at 1-month and 3-month periods on healthy adult volunteers. The amount of product provided has been estimated to last 3 months at which the empty containers will be returned.

Sponsors

Skin Surgery Clinic
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy volunteers, aged between 25 and 75 without acute or chronic skin diseases will be enrolled.

Exclusion criteria

Anyone with skin diseases, acute or chronic, those unable to provide informed consent, or those with a history of allergies or sensitivities to any of the ingredients in the study products. For females, pregnancy (or planned pregnancy during he study period) will also be an exclusion.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026